Two studies published today measure the vaccine effectiveness (VE) of COVID-19 vaccines against laboratory-confirmed Omicron variant and subvariants and symptomatic disease. Vaccines that target the newer variants performed well, but primary vaccines offered rapidly waning protection from SARS-CoV-2 infections in the post-Omicron era.
Problem, Solution, SitRep, or ?:
Recent Comments